A carregar...
User preference for a portable syringe pump for iloprost infusion
PURPOSE: Administration of intravenous iloprost – a first-line European League Against Rheumatism (EULAR)-recommended choice for the treatment of scleroderma (SSc)-related digital vasculopathy – requires repeated treatment cycles of 6 hours per day in a hospital setting. During the infusion, patient...
Na minha lista:
| Publicado no: | Patient Relat Outcome Meas |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4447001/ https://ncbi.nlm.nih.gov/pubmed/26056502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S81473 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|